Covered recipient · General Payments record
SPENCER THOMAS WHEALON
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$2,117.78
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.45 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insmed, Inc. | $69.58 | 2 |
| GENZYME CORPORATION | $64.91 | 2 |
| GlaxoSmithKline, LLC. | $48.77 | 2 |
| Electromed, Inc. | $37.44 | 1 |
| Genentech USA, Inc. | $26.82 | 1 |
| ABBVIE INC. | $24.90 | 1 |
| Relypsa, Inc. | $22.03 | 1 |
| Mylan Specialty L.P. | $21.67 | 1 |
| Acerta Pharma LLC | $20.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.90 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106329951 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.33 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104692384 | CMS |
| Electromed, Inc. | $37.44 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137916274 | CMS |
| Genentech USA, Inc. | $26.82 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133114652 | CMS |
| GENZYME CORPORATION | $36.78 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139835414 | CMS |
| GENZYME CORPORATION | $28.13 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139835486 | CMS |
| GlaxoSmithKline, LLC. | $16.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115941341 | CMS |
| GlaxoSmithKline, LLC. | $32.73 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116431915 | CMS |
| Insmed, Inc. | $34.65 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089555960 | CMS |
| Insmed, Inc. | $34.93 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089570456 | CMS |
| Mylan Specialty L.P. | $21.67 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147317992 | CMS |
| Vifor Pharma, Inc. | $22.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124068087 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.